SK Biopharmaceuticals Co., Ltd. (KRX:326030)
98,100
-600 (-0.61%)
Mar 12, 2026, 9:29 AM KST
-8.23% (1Y)
| Market Cap | 7.73T -20.7% |
| Revenue (ttm) | 675.41B +32.1% |
| Net Income | 320.47B +458.5% |
| EPS | 4,092.19 +458.8% |
| Shares Out | 78.31M |
| PE Ratio | 24.12 |
| Forward PE | 29.23 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,082 |
| Average Volume | 279,951 |
| Open | 98,600 |
| Previous Close | 98,700 |
| Day's Range | 97,900 - 99,000 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.76 |
| RSI | 37.48 |
| Earnings Date | May 11, 2026 |